Amid shortages, U.S. allows expanded production of ADHD drug Vyvanse
The maker of the ADHD drug Vyvanse has been given approval by the U.S. Drug Enforcement Administration to make more of the medication as a shortage of the critical drugs continues.
Sep 5, 2024
0
49









